Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients

Lise Lotte Christensen; Reetta Kariola; Mari K Korhonen; Friedrik P Wikman; Lone Sunde; Anne-Marie Gerdes; Henrik Okkels; Carsten A Brandt; Inge Bernstein; Thomas V O Hansen; Rikke Hagemann-Madsen; Claus L Andersen; Minna Nyström; Torben F Ørntoft; Lise Christensen; Reetta Kariola; Mari Korhonen; Friedrik Wikman; Lone Sunde; Anne-Marie Gerdes; Henrik Okkels; Carsten Brandt; Inge Bernstein; Thomas Hansen; Rikke Hagemann-Madsen; Claus Andersen; Minna Nyström; Torben Orntoft

doi:10.1007/s10689-009-9274-4

Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients

Lise Lotte Christensen, Reetta Kariola, Mari K Korhonen, Friedrik P Wikman, Lone Sunde, Anne-Marie Gerdes, Henrik Okkels, Carsten A Brandt, Inge Bernstein, Thomas V O Hansen, Rikke Hagemann-Madsen, Claus L Andersen, Minna Nyström, Torben F Ørntoft, Lise Christensen, Reetta Kariola, Mari Korhonen, Friedrik Wikman, Lone Sunde, Anne-Marie GerdesHenrik Okkels, Carsten Brandt, Inge Bernstein, Thomas Hansen, Rikke Hagemann-Madsen, Claus Andersen, Minna Nyström, Torben Orntoft

Department of Clinical Medicine

8 Citations (Scopus)

Abstract

Recently, we have performed a population based study to analyse the frequency of colorectal cancer related MLH1 and MSH2 missense mutations in the Danish population. Half of the analyzed mutations were rare and most likely only present in the families where they were identified originally. Some of the missense mutations were located in conserved regions in the MLH1 and MSH2 proteins indicating a relation to disease development. In the present study, we functionally characterized 10 rare missense mutations in MLH1 and MSH2 identified in 13 Danish CRC families. To elucidate the pathogenicity of the missense mutations, we carried out in vitro functional analyses. The missense mutations were analyzed for their effect on protein expression and repair efficiency. The results of the functional analysis were correlated with clinical data on the families carrying these mutations. Eight missense mutations resulted in proteins with expression and repair efficiency similar to the wild type. One missense mutation (MSH2 p.Met688Val) caused reduced protein expression and one (MSH2 p.Leu187Arg) caused both reduced protein expression and repair deficiency. The MSH2 p.Leu187Arg mutation was found in an Amsterdam II family presenting with high microsatellite instability and loss of MSH2 and MSH6 proteins in tumours. In conclusion, only 1/10 missense mutations displayed repair deficiency and could be classified as pathogenic. No final conclusion can be drawn on the MSH2 p.Met688Val mutation, which caused reduced protein expression. Although, no deficiencies have been identified in the proteins harbouring the other missense mutations, pathogenicity of these variants cannot be unambiguously excluded.

Original language	English
Journal	Familial Cancer
Volume	8
Issue number	4
Pages (from-to)	489-500
Number of pages	11
ISSN	1389-9600
DOIs	https://doi.org/10.1007/s10689-009-9274-4 https://doi.org/10.1007/s10689-009-9274-4
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Cite this

Christensen, L. L., Kariola, R., Korhonen, M. K., Wikman, F. P., Sunde, L., Gerdes, A-M., Okkels, H., Brandt, C. A., Bernstein, I., Hansen, T. V. O., Hagemann-Madsen, R., Andersen, C. L., Nyström, M., Ørntoft, T. F., Christensen, L., Kariola, R., Korhonen, M., Wikman, F., Sunde, L., ... Orntoft, T. (2009). Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients. Familial Cancer, 8(4), 489-500. https://doi.org/10.1007/s10689-009-9274-4, https://doi.org/10.1007/s10689-009-9274-4

Christensen, LL, Kariola, R, Korhonen, MK, Wikman, FP, Sunde, L, Gerdes, A-M, Okkels, H, Brandt, CA, Bernstein, I, Hansen, TVO, Hagemann-Madsen, R, Andersen, CL, Nyström, M, Ørntoft, TF, Christensen, L, Kariola, R, Korhonen, M, Wikman, F, Sunde, L, Gerdes, A-M, Okkels, H, Brandt, C, Bernstein, I, Hansen, T, Hagemann-Madsen, R, Andersen, C, Nyström, M & Orntoft, T 2009, 'Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients', Familial Cancer, vol. 8, no. 4, pp. 489-500. https://doi.org/10.1007/s10689-009-9274-4, https://doi.org/10.1007/s10689-009-9274-4

@article{de7bf250aabd11df928f000ea68e967b,

title = "Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients",

abstract = "Recently, we have performed a population based study to analyse the frequency of colorectal cancer related MLH1 and MSH2 missense mutations in the Danish population. Half of the analyzed mutations were rare and most likely only present in the families where they were identified originally. Some of the missense mutations were located in conserved regions in the MLH1 and MSH2 proteins indicating a relation to disease development. In the present study, we functionally characterized 10 rare missense mutations in MLH1 and MSH2 identified in 13 Danish CRC families. To elucidate the pathogenicity of the missense mutations, we carried out in vitro functional analyses. The missense mutations were analyzed for their effect on protein expression and repair efficiency. The results of the functional analysis were correlated with clinical data on the families carrying these mutations. Eight missense mutations resulted in proteins with expression and repair efficiency similar to the wild type. One missense mutation (MSH2 p.Met688Val) caused reduced protein expression and one (MSH2 p.Leu187Arg) caused both reduced protein expression and repair deficiency. The MSH2 p.Leu187Arg mutation was found in an Amsterdam II family presenting with high microsatellite instability and loss of MSH2 and MSH6 proteins in tumours. In conclusion, only 1/10 missense mutations displayed repair deficiency and could be classified as pathogenic. No final conclusion can be drawn on the MSH2 p.Met688Val mutation, which caused reduced protein expression. Although, no deficiencies have been identified in the proteins harbouring the other missense mutations, pathogenicity of these variants cannot be unambiguously excluded.",

author = "Christensen, {Lise Lotte} and Reetta Kariola and Korhonen, {Mari K} and Wikman, {Friedrik P} and Lone Sunde and Anne-Marie Gerdes and Henrik Okkels and Brandt, {Carsten A} and Inge Bernstein and Hansen, {Thomas V O} and Rikke Hagemann-Madsen and Andersen, {Claus L} and Minna Nystr{\"o}m and {\O}rntoft, {Torben F} and Lise Christensen and Reetta Kariola and Mari Korhonen and Friedrik Wikman and Lone Sunde and Anne-Marie Gerdes and Henrik Okkels and Carsten Brandt and Inge Bernstein and Thomas Hansen and Rikke Hagemann-Madsen and Claus Andersen and Minna Nystr{\"o}m and Torben Orntoft",

note = "Keywords: Adaptor Proteins, Signal Transducing; Adult; Blotting, Western; Colorectal Neoplasms; Denmark; Female; Humans; Male; Middle Aged; MutS Homolog 2 Protein; Mutagenesis, Site-Directed; Mutation, Missense; Nuclear Proteins; Pedigree",

year = "2009",

doi = "10.1007/s10689-009-9274-4",

language = "English",

volume = "8",

pages = "489--500",

journal = "Familial Cancer",

issn = "1389-9600",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients

AU - Christensen, Lise Lotte

AU - Kariola, Reetta

AU - Korhonen, Mari K

AU - Wikman, Friedrik P

AU - Sunde, Lone

AU - Gerdes, Anne-Marie

AU - Okkels, Henrik

AU - Brandt, Carsten A

AU - Bernstein, Inge

AU - Hansen, Thomas V O

AU - Hagemann-Madsen, Rikke

AU - Andersen, Claus L

AU - Nyström, Minna

AU - Ørntoft, Torben F

AU - Christensen, Lise

AU - Kariola, Reetta

AU - Korhonen, Mari

AU - Wikman, Friedrik

AU - Sunde, Lone

AU - Gerdes, Anne-Marie

AU - Okkels, Henrik

AU - Brandt, Carsten

AU - Bernstein, Inge

AU - Hansen, Thomas

AU - Hagemann-Madsen, Rikke

AU - Andersen, Claus

AU - Nyström, Minna

AU - Orntoft, Torben

N1 - Keywords: Adaptor Proteins, Signal Transducing; Adult; Blotting, Western; Colorectal Neoplasms; Denmark; Female; Humans; Male; Middle Aged; MutS Homolog 2 Protein; Mutagenesis, Site-Directed; Mutation, Missense; Nuclear Proteins; Pedigree

PY - 2009

Y1 - 2009

N2 - Recently, we have performed a population based study to analyse the frequency of colorectal cancer related MLH1 and MSH2 missense mutations in the Danish population. Half of the analyzed mutations were rare and most likely only present in the families where they were identified originally. Some of the missense mutations were located in conserved regions in the MLH1 and MSH2 proteins indicating a relation to disease development. In the present study, we functionally characterized 10 rare missense mutations in MLH1 and MSH2 identified in 13 Danish CRC families. To elucidate the pathogenicity of the missense mutations, we carried out in vitro functional analyses. The missense mutations were analyzed for their effect on protein expression and repair efficiency. The results of the functional analysis were correlated with clinical data on the families carrying these mutations. Eight missense mutations resulted in proteins with expression and repair efficiency similar to the wild type. One missense mutation (MSH2 p.Met688Val) caused reduced protein expression and one (MSH2 p.Leu187Arg) caused both reduced protein expression and repair deficiency. The MSH2 p.Leu187Arg mutation was found in an Amsterdam II family presenting with high microsatellite instability and loss of MSH2 and MSH6 proteins in tumours. In conclusion, only 1/10 missense mutations displayed repair deficiency and could be classified as pathogenic. No final conclusion can be drawn on the MSH2 p.Met688Val mutation, which caused reduced protein expression. Although, no deficiencies have been identified in the proteins harbouring the other missense mutations, pathogenicity of these variants cannot be unambiguously excluded.

AB - Recently, we have performed a population based study to analyse the frequency of colorectal cancer related MLH1 and MSH2 missense mutations in the Danish population. Half of the analyzed mutations were rare and most likely only present in the families where they were identified originally. Some of the missense mutations were located in conserved regions in the MLH1 and MSH2 proteins indicating a relation to disease development. In the present study, we functionally characterized 10 rare missense mutations in MLH1 and MSH2 identified in 13 Danish CRC families. To elucidate the pathogenicity of the missense mutations, we carried out in vitro functional analyses. The missense mutations were analyzed for their effect on protein expression and repair efficiency. The results of the functional analysis were correlated with clinical data on the families carrying these mutations. Eight missense mutations resulted in proteins with expression and repair efficiency similar to the wild type. One missense mutation (MSH2 p.Met688Val) caused reduced protein expression and one (MSH2 p.Leu187Arg) caused both reduced protein expression and repair deficiency. The MSH2 p.Leu187Arg mutation was found in an Amsterdam II family presenting with high microsatellite instability and loss of MSH2 and MSH6 proteins in tumours. In conclusion, only 1/10 missense mutations displayed repair deficiency and could be classified as pathogenic. No final conclusion can be drawn on the MSH2 p.Met688Val mutation, which caused reduced protein expression. Although, no deficiencies have been identified in the proteins harbouring the other missense mutations, pathogenicity of these variants cannot be unambiguously excluded.

U2 - 10.1007/s10689-009-9274-4

DO - 10.1007/s10689-009-9274-4

M3 - Journal article

C2 - 19697156

SN - 1389-9600

VL - 8

SP - 489

EP - 500

JO - Familial Cancer

JF - Familial Cancer

IS - 4

ER -

Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this